Utah GOP Senator Defends Modified Cannabis Bill for Creating 'More Guardrails'
*By Chloe Aiello*
Medical marijuana is now legal in Utah, but not exactly in the form voters intended. Shortly after the medical marijuana initiative, Proposition 2, was scheduled to go into effect, the Utah state House and Senate swooped in and replaced it with a new law.
Wayne Niederhauser, a Republican senator for Utah's 9th district, defended the move on Wednesday, and told Cheddar the new law, "The Utah Medical Cannabis Act," ensures "medical marijuana and not de-facto recreational" is the law of the Beehive State.
"We wanted to create some more guardrails. We want to get medical marijuana to everyone that needs it, but we also have 600,000 plus children in this state, and we want to make sure those children are protected as much as possible from getting a controlled substance," Niederhauser said.
"The Utah Medical Cannabis Act" that Gov. Gary Herbert signed into law on Monday differs in some significant ways from Proposition 2. The bill reduces the permitted number of privately-run dispensaries for the state, Niederhauser said ー supplementing them instead with state-run distribution through health departments. Cannabis "flower" is still allowed, but only in one-gram increments, and edibles are mostly illegal, except for gummy cubes, according to the [Salt Lake Tribune](https://www.sltrib.com/news/politics/2018/12/03/utah-house-passes-medical/). It also tweaks the list of conditions that qualify for treatment.
Niederhauser said, "there's really not a lot of difference," between Prop 2 and the new bill, but cannabis advocacy group Marijuana Policy Project disagreed.
“This bill is undoubtedly inferior to the law enacted by voters in November. However, Proposition 2 would very likely have been defeated without the compromise deal, which prevented an onslaught of opposition spending. Advocates made the responsible decision to negotiate with opponents and ensure that patients were not left without any access to medical cannabis," MPP's Matthew Schweich [said in a statement](https://www.mpp.org/news/press/utah-legislature-passes-compromise-medical-marijuana-law/) after the new bill passed.
"The Utah Medical Cannabis Act" was a collaboration between lawmakers and medical marijuana proponents that "came to fruition" about 45 days before the midterms, Niederhauser said, adding that whether or not Prop 2 passed, the medical law would have been enacted. The new program is expected to be running by 2020.
As to whether the new law will lead to recreational legalization, Niederhauser said he hopes not.
"As far as I'm concerned, I hope we never even get close to recreational use," he said.
For full interview [click here](https://cheddar.com/videos/recreational-marijuana-shouldnt-be-legal-in-utah-according-to-state-senate-president).
Matt Faubion, Wealth Manager and Investment Adviser at Faubion Wealth Management, joins Cheddar to break down the pros and cons to gifting and receiving investments, like stock or cryptocurrency, as a gift this holiday season.
President Joe Biden is expected to meet with his COVID-19 response team as the omicron variant continues to surge across the country. Experts say Delta is driving this surge but Dr. Anthony Fauci says Omicron will take over. Emergency physician Dr. Daniel Fagbuyi joins Cheddar News to discuss.
Trip.com is now adding Hopper's price freeze feature for its users. The feature will help travelers save money by protecting them from pricing volatility when booking their next trip. The company is the first online travel agency to partner with Hopper's B2B initiative, Hopper Cloud. Dakota Smith, chief strategy officer at Hopper, joins Cheddar News to walk us through the feature and how the company is addressing Omicorn concerns.
'Spider-Man: No Way Home' caught moviegoers in its web this weekend at the box office. The film premiered at $260 million in U.S. ticket sales, making it the second-best domestic debut of all time and the biggest opening since the pandemic began. Shawn Robbins, chief analyst at BoxofficePro.com, joins Cheddar News to discuss the film's success.
Spider-Man is hoping to come to the rescue of movie theaters as they struggle to recover from the pandemic. "Spider-Man: No Way Home" starring Tom Holland is officially out in theaters and is expected to generate a whopping $150 million in its box office debut. Sean O'Connell, managing editor of CinemaBlend, joined Cheddar to discuss his expectations for the new Marvel movie, and what the entertainment industry is doing to prepare for a potential winter surge in COVID cases.
With the resurgence in COVID cases and the uncertainty of the Omicron variant, many companies, like Apple, Ford, Google, and countless others, are delaying their return-to-office dates. This means employees will continue to work from home full time or continue a hybrid approach, which can cause some challenges. Executive coach Stefania Romeo joined Cheddar to discuss how companies can best manage the difficulties of hybrid work.
Rebecca Minkoff is launching a new initiative through her non-profit, Female Founder Collective. A former Wall Street analyst and financial strategist will be coaching new founders to focus on their financial transformation, from getting their business financially organized to uncovering opportunities to increase revenue. The renowned founder and fashion designer joined Cheddar to discuss this new program and the advice she gives to female founders hoping to get their business off the ground.
Carlo's joined by a quarantining Baker to discuss the headlines from the weekend as Omicron spreads like wildfire, Manchin kills Biden's signature bill and Spider-Man throws a lifeline to the box office.
Travis Clark, senior media reporter at Insider, joined 'Wake Up With Cheddar' to break down the $253 million domestic opening for the new Marvel movie. This also marked the third-largest global opening of all time, earning $587 million worldwide, even though it wasn't released in China, which is a major market for moviegoers.
